Cannvalate Pty was founded early 2018 by doctors and healthcare experts to hone in on the late part of the cannabis value chain. Cannvalate's was drawn to a position of the custodian of the Australian medical cannabis industry. Cannvalate's primary focus is evidence-based medicine. We have nurtured a strong alliance with the medical community. We are a B2B service provider that is committed to demonstrating medication safety and efficacy both through our clinical research via the Medicinal Cannabis Research Collaboration (MCRC) with Swinburne University and through our patient access program, Australian Cannabis Market Access (ACMA). We also provide market entry projects across APAC region with strategically selected global companies in the cannabis industry.